HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hesong Cui Selected Research

pradefovir

10/2022Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hesong Cui Research Topics

Disease

1Liver Cirrhosis (Hepatic Cirrhosis)
10/2022
1Chronic Hepatitis B
10/2022
1Neoplasms (Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

1pradefovirIBA
10/2022
1Hepatitis B e AntigensIBA
10/2022
1Biomarkers (Surrogate Marker)IBA
01/2019